300+ investors in your industry, stage, and region Get
Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
Oman
Poland
Puerto Rico
Guernsey
Cameroon
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
South Africa
Moldova
Seychelles
Botswana
Paraguay
Canada
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
United States
Ireland
India
Germany
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
Ukraine
San Marino
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Biotech Startup Investors in Austria (September 2026)

The most active venture capital funds and angel investors investing in Austria Biotech startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Austria Biotech startup companies. Find investors to raise a Pre-Seed, Seed or Series A round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
XISTA Science Ventures
VC Fund
18 Austria, Germany, France Seed, Pre-Seed, Series A Biotechnology, Medical, Software $548k–$20M
xista science ventures
VC Fund
9 Austria, Slovenia Seed, Pre-Seed, Series A Biotechnology, Medical, Software $552k–$20M
tecnet equity
VC Fund
9 Austria Seed, Series A Software, Biotechnology, Artificial Intelligence $400k–$20M
austria Wirtschaftsservice (aws)
VC Fund
6 Austria, Belgium Seed, Grant, Pre-Seed Software, Information Technology, Artificial Intelligence $61k–$2.7M
SOSV
VC Fund
5 United States, India, United Kingdom Seed, Convertible Note, Pre-Seed Biotechnology, Health Care, Software
aws Gründungsfonds
VC Fund
4 Austria, Germany, United States Seed, Series A Software, SaaS, Information Technology $1.1M–$11M
MIG Capital
VC Fund
4 Germany, France, Austria Series A, Series B, Seed Biotechnology, Health Care, Software $1.3M–$60M
10x Founders
VC Fund
3 Germany, United States, Switzerland Seed, Series A, Pre-Seed Software, Artificial Intelligence, Information Technology $620k–$53M
Arax Capital Partners
VC Fund
3 Austria, United States Seed, Venture - Series Unknown, Series A Biotechnology, Software, Health Care $600k–$10M
PUSH VC
VC Fund
3 Austria, Germany, United States Seed, Series A Software, Apps, Health Care $650k–$31M
Lansdowne Partners
VC Fund
3 United Kingdom, Austria, United States Series A, Series B Biotechnology, Finance, Genetics $6.7M–$100M
FPS-Holding
VC Fund
3 Austria Seed Biotechnology, Health Diagnostics $420k–$1.5M
BackBone Ventures
VC Fund
2 Switzerland, Germany, Israel Pre-Seed, Seed, Series A Artificial Intelligence, Software, Information Technology $578k–$105M
Verge HealthTech Fund
VC Fund
2 Estonia, Singapore, United States Seed, Pre-Seed, Series A Health Care, Medical, Medical Device $500k–$4.7M
Simon Capital
VC Fund
2 Germany, Austria, The Netherlands Series A, Seed, Series B Software, Biotechnology, Food and Beverage $1.7M–$57M
Nina Capital
VC Fund
2 United States, United Kingdom, Germany Seed, Pre-Seed, Series A Health Care, Artificial Intelligence, Software $529k–$21M
APEX Ventures
VC Fund
2 Germany, United Kingdom, Austria Seed, Series A, Pre-Seed Artificial Intelligence, Software, Health Care $552k–$28M
KHAN Technology Transfer Fund
VC Fund
2 Germany, Austria, Belgium Seed, Pre-Seed, Series A Biotechnology, Medical, Biopharma $259k–$10M
Hadean Ventures
VC Fund
2 Sweden, Norway, Austria Series A, Series B, Venture - Series Unknown Biotechnology, Health Care, Medical $2M–$79M
Longevitytech.fund
VC Fund
2 United States, United Kingdom, The Netherlands Seed, Convertible Note, Pre-Seed Biotechnology, Health Care, Life Science $100k–$10M
Übermorgen Ventures
VC Fund
2 Germany, Switzerland, Finland Seed, Pre-Seed, Series A Energy, Software, SaaS $300k–$12M
TSVC
VC Fund
2 United States, China, Canada Seed, Series A Software, Artificial Intelligence, Health Care $500k–$44M
The Austrian Research Promotion Agency (FFG)
VC Fund
2 Austria, United States, Belgium Grant, Seed, Pre-Seed Software, Artificial Intelligence, Medical $67k–$3.5M
Aescap Venture
VC Fund
2 Switzerland, United Kingdom, The Netherlands Series B, Series A, Series C Biotechnology, Pharmaceutical, Health Diagnostics $1.5M–$33M
Axilium Holding
VC Fund
2 Sweden, Austria Seed, Venture - Series Unknown Software, Human Resources, FinTech $450k–$7.3M
MCI Capital SA
VC Fund
2 Poland, United Kingdom, Germany Series A, Venture - Series Unknown, Series C E-Commerce, Software, Financial Services $603k–$45M
Gamma Capital Partners
VC Fund
2 Austria, United States, Germany Series A, Seed Software, Manufacturing, Information Technology $409k–$8M
SkyGene
VC Fund
2 Austria Venture - Series Unknown Medical, Health Care, Biotechnology
HTGF (High-Tech Gruenderfonds)
VC Fund
2 Germany, Switzerland, United States Seed, Series A Software, Biotechnology, Information Technology $850k–$31M
Schnidar Harald
Angel
2 Austria Seed, Angel, Pre-Seed Software, Biopharma, Cosmetics
GreyBird Ventures
VC Fund
2 United States, Germany, China Series A, Seed Health Care, Medical, Biotechnology $3M–$16M
Open Field Capital
VC Fund
2 United States, Austria, United Kingdom Venture - Series Unknown, Series A, Seed Artificial Intelligence, Software, Machine Learning $150k–$350M
bmp Ventures
VC Fund
2 Germany, United States, Austria Seed, Series A Software, Information Technology, Manufacturing $162k–$5.9M
R42 Group
VC Fund
2 United Kingdom, United States, Austria Seed, Pre-Seed, Series A Biotechnology, Health Care, Software $472k–$40M
ICL Planet Startup Hub
VC Fund
2 Israel, Austria Seed Biotechnology, Agriculture, AgTech $4.3M–$10M
Ligand Pharmaceuticals
VC Fund
2 United States, Austria, Denmark Post-IPO Debt, Corporate Round, Post-IPO Equity Biotechnology, Medical, Health Care $3M–$90M
red-stars.com
VC Fund
2 Austria, Germany Seed, Venture - Series Unknown Software, Biotechnology, Telecommunications $1.1M–$4.4M
VP Venture Partners
VC Fund
2 Austria, Switzerland Seed Medical, Health Diagnostics, Internet $3M–$6.9M
eQventure
VC Fund
2 Austria, Germany, Switzerland Seed, Series A, Series B Software, Information Technology, Automotive $540k–$13M
Novartis Venture Fund
VC Fund
1 United States, Switzerland, United Kingdom Series B, Series A, Series C Biotechnology, Health Care, Therapeutics $5.1M–$120M
Synthesis Capital
VC Fund
1 United States, Israel, Austria Seed, Series A, Series C Biotechnology, Food and Beverage, Organic Food $7.1M–$23M
HBM Partners
VC Fund
1 United States, Germany, Switzerland Series B, Series C Biotechnology, Medical, Health Care $2.5M–$125M
Amino Collective
VC Fund
1 United States, United Kingdom, Germany Seed, Series A, Pre-Seed Biotechnology, Health Care, Artificial Intelligence $125k–$37M
OrbiMed
VC Fund
1 United States, China, Israel Series B, Series A, Series C Biotechnology, Health Care, Medical $10M–$183M
PONTIS Venture Partners Management
VC Fund
1 Austria, Germany Series A, Series B, Series C Software, Manufacturing, Information Technology
IPO Beteiligungs-Management
VC Fund
1 Austria Series B Sensor, Medical, Wireless
IBG Beteiligungsgesellschaft Sachsen-Anhalt
VC Fund
1 Germany, Austria Seed, Series A Electronics, Software, Medical Device
ReGen Ventures
VC Fund
1 United States, Austria, United Kingdom Seed, Series A, Series B Agriculture, Biotechnology, Farming
Climentum Capital
VC Fund
1 Sweden, Spain, Austria Seed, Series A, Series B CleanTech, Clean Energy, Biotechnology
Techno Venture Management
VC Fund
1 United States, Germany, United Kingdom Series B, Series A Biotechnology, Health Care, Pharmaceutical
Access all 205 investors in Austria Biotech startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

XISTA Science Ventures
VC Fund · Klosterneuburg, Niederosterreich, Austria · 18 investments in Austria Biotech startups, 11 in the past 12 months

We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Austria, Germany, France

Investor stats

  • Total investments: 47
  • Round size: Seed $1.8M–$6.9M; Pre-Seed $548k–$1.7M; Series A $5.7M–$20M
  • Lead/follow: 57% lead, 43% follow

Portfolio highlights

  • Rivus Batteries — Rivus is a start-up that serves as the commercialization platform for the aqueous organic flow battery technology.
  • Ora Computing — We make AI models smaller, faster, and more efficient.
  • Epitome Therapeutics — Epitome Therapeutics is an early-stage biotechnology company developing CADENCE, a next-generation epigenome editing platform for precise, durable, and context-dependent control of gene expression without altering the underlying DNA sequence, with the aim of establishing a new therapeutic modality for diseases driven by dysregulated gene activity.
Show all investments...

xista science ventures
VC Fund · Klosterneuburg, Niederosterreich, Austria · 9 investments in Austria Biotech startups

We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Austria, Slovenia

Investor stats

  • Total investments: 22
  • Round size: Seed $1.8M–$7.3M; Pre-Seed $552k–$1.5M; Series A $5.7M–$20M
  • Lead/follow: 64% lead, 36% follow

Portfolio highlights

  • subdron — subdron turns the seabed from a blind spot into a monitored domain.
  • infrared.city — Redefine environmental simulations. Our bespoke AI models revolutionise performative design, slashing time, cost, and complexity. Access cutting-edge services effortlessly because innovation should be for everyone
  • VALANX Biotech — VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.
Show all investments...

tecnet equity
VC Fund · Sankt Polten, Niederosterreich, Austria · 9 investments in Austria Biotech startups

tecnet equity is an Austrian venture capital fund investing in innovative high-tech companies with potential for significant growth.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Artificial Intelligence
  • Stage:Seed, Series A
  • Geography: Austria

Investor stats

  • Total investments: 76
  • Round size: Seed $400k–$2.5M; Series A $557k–$20M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: May invest from a new fund soon — raised $33M in 2009

Portfolio highlights

  • PROPCORN AI — At PROPCORN, our goal is to harness the power of AI to automatically unlock the full real estate building potential of our customers, enabling them to make faster and more accurate decisions in real-time.
  • deepentix — Deepentix provides a graph-as-a-service platform that converts unstructured documents into verifiable claim graphs. Its software extracts semantic claims, qualifiers, constraints, and confidence information, then links entities to domain ontologies. The Claim Graph API supports natural-language and API-based queries with paragraph-level citations,conflict flags, policy checks, and provenance paths. Private extractors use domain-tuned small language models for organization-specific templates and terminology. Deepentix also offers hosted and on-premises graph deployments that can integrate with systems such as electronic laboratory notebooks, laboratory information management systems, claims systems, and chat copilots. The platform is intended for regulated workflows in life sciences, insurance, legal and regulatory work, and climate and ESG analysis where document-based decisions require traceability and audit records.
  • VALANX Biotech — VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.
Show all investments...

austria Wirtschaftsservice (aws)
VC Fund · Vienna, Wien, Austria · 6 investments in Austria Biotech startups, 8 in the past 12 months

The Austrian Economic Service mbH (aws) is the promotional bank of the Federal Government.The aws SME fund is the largest Austrian Fund for silent corporate investments, but also providers of equity. Founded in late 2009 by the Austrian Economic Service mbH (aws) - the Development Bank of the Federal - he has a term until 31/12/2025.The fund is currently endowed with EUR 80 million and participates in medium-sized companies and brings with it a fresh capital to develop new products or processes, for sales development to international expansion.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Grant, Pre-Seed
  • Geography: Austria, Belgium

Investor stats

  • Total investments: 76
  • Round size: Seed $452k–$2.7M; Grant $61k–$2.3M; Pre-Seed $195k–$1.6M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: May invest from a new fund soon — raised $92M in 2013

Portfolio highlights

  • Repentium — We strive to create
  • Graph Therapeutics — Graph Therapeutics - precision immunology
  • Epitome Therapeutics — Epitome Therapeutics is an early-stage biotechnology company developing CADENCE, a next-generation epigenome editing platform for precise, durable, and context-dependent control of gene expression without altering the underlying DNA sequence, with the aim of establishing a new therapeutic modality for diseases driven by dysregulated gene activity.
Show all investments...

SOSV
VC Fund · Princeton, New Jersey, United States · 5 investments in Austria Biotech startups, 75 in the past 12 months

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Convertible Note, Pre-Seed
  • Geography: United States, India, United Kingdom

Investor stats

  • Total investments: 1482
  • Lead/follow: no public data

Portfolio highlights

  • MixRift — MIXRIFT - game developers specialized in Mixed Reality
  • unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
  • Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Show all investments...

aws Gründungsfonds
VC Fund · Vienna, Wien, Austria · 4 investments in Austria Biotech startups

aws Gründerfonds is Austria's 70m venture capital fund. We invest as co-investor in Austrian high-growth start-ups in their later seed and (pre-)series-A stages.

Show more...

Investment focus

  • Industry: Software, SaaS, Information Technology
  • Stage:Seed, Series A
  • Geography: Austria, Germany, United States

Investor stats

  • Total investments: 100
  • Round size: Seed $1.3M–$5.2M; Series A $1.1M–$11M
  • Lead/follow: 14% lead, 86% follow
  • Last fund: Likely still investing — raised $77M in 2023

Portfolio highlights

  • refinq — Asset-level climate and nature risk analytics for banks, insurers and corporates. Audit-ready data for CSRD, EU Taxonomy, EBA Pillar 3, SFDR and TNFD.
  • vitrealab — Enlighten. Your perspective. Light Engines for AR glasses.
  • Invisible-Light Labs — Invisible Light Labs uses Fourier transform infrared (FTIR) spectroscopy and nanoelectromechanical sensing technologies to enable chemical analysis of materials and nanomaterials that are available in minuscule amounts in a variety of industries, from environmental monitoring to pharmaceuticals.
Show all investments...

MIG Capital
VC Fund · München, Bayern, Germany · 4 investments in Austria Biotech startups

MIG Capital is one of the leading German VC Investors. We invest in European Deep Tech and Life Sciences from early to late stage (Seed, Series A, and beyond). We use investments to shape a better tomorrow, today. Our team currently manages 17 MIG public venture capital funds regulated by BaFin, the German financial markets authority. These fundsoperate with more than EUR 1.2 billion capital committed by >60,000 private investors across Germany and Austria.Today, our portfolio consists of 30 companies.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series A, Series B, Seed
  • Geography: Germany, France, Austria

Investor stats

  • Total investments: 98
  • Round size: Seed $1.3M–$13M; Series A $2.2M–$40M; Series B $1.7M–$60M
  • Lead/follow: 45% lead, 55% follow
  • Last fund: May invest from a new fund soon — raised $76M in 2014

Portfolio highlights

  • NcodiN — The High Performance Computing (HPC) and ArtificiaI Intelligence (AI) era requires unprecedented computing capabilities. With this in view, industry is heading towards zettascale supercomputers, based on >100k processing units. Chiplets-based disaggregated processors and memory-centric computing architectures are taking over and require an ever more intensive communication between dies. Thus, today interconnect bottleneck is the main
  • GlassPoint Solar — GlassPoint provides solar steam generators to the oil and gas industry for applications such as Enhanced Oil Recovery. It replaces gas-fired steam generation with solar, GlassPoint can reduce EOR gas consumption by up to 80 percent. The company was founded in 2008 and headquartered in Fremont, California.
  • Zadient Technologies — Zadient produces semiconductor manufacturing materials that are critical for the entire silicon carbide (SiC) value chain
Show all investments...

10x Founders
VC Fund · Munich, Bayern, Germany · 3 investments in Austria Biotech startups

Cutting-edge venture capital firm supporting the early-stage entrepreneurs building global businesses.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Germany, United States, Switzerland

Investor stats

  • Total investments: 94
  • Round size: Seed $2.5M–$10M; Pre-Seed $620k–$5M; Series A $6.7M–$53M
  • Lead/follow: 15% lead, 85% follow
  • Last fund: Likely still investing — raised $168M in 2022

Portfolio highlights

  • Logicc — Logicc provides business solutions for various industries. It specializes in software development, automation, and data-driven technologies.
  • Qorelo — Qorelo is a tech company that provides agentic AI software designed to accelerate ERP transformations. Qorelo's software automates and structures deliverables across the SAP Activate methodology.
  • Arlequin AI — Unlock actionable insights from complex social data to drive strategic decisions using our AI models.
Show all investments...

Arax Capital Partners
VC Fund · Vienna, Wien, Austria · 3 investments in Austria Biotech startups

ARAX Capital Partners is an Austrian bio-tech and high-tech early stage investor with an exclusive focus on Austrian ventures. Companies need to be young, innovative (if possible with patentable technology) and must have already secured pre-seed funding to qualify for an investment

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: Austria, United States

Investor stats

  • Total investments: 11
  • Round size: Seed $687k–$1.1M; Venture - Series Unknown $600k–$10M
  • Lead/follow: 45% lead, 55% follow
  • Last fund: May invest from a new fund soon — raised $88M in 2008

Portfolio highlights

  • Greenpass — Greenpass is an all-in-one SaaS for climate-resilient urban planning & architecture platform that enables livable cities.
  • Calyxha Biotechnologies — A new perspective on inflammation
  • EveliQure Biotechnologies GmbH — EveliQure was founded in 2012 with headquarters in Vienna and developed for the first time a combined vaccine, which is intended to protect against Shigella as well as against ETEC bacteria. Both bacterial strains cause various types of diarrheal diseases, and all attempts at development of vaccines have so far only aimed to protect against one ofthe two bacterial strains. The team led by Managing Director Gábor Somogyi has succeeded for the first time in producing a combined swallow vaccine that simultaneously protects against both bacterial strains.
Show all investments...

PUSH VC
VC Fund · Vienna, Wien, Austria · 3 investments in Austria Biotech startups

We are an early-stage Venture Capital Firm investing in outstanding teams with convincing products and high growth potential.

Show more...

Investment focus

  • Industry: Software, Apps, Health Care
  • Stage:Seed, Series A
  • Geography: Austria, Germany, United States

Investor stats

  • Total investments: 46
  • Round size: Seed $650k–$8.1M; Series A $5M–$31M
  • Lead/follow: 17% lead, 83% follow
  • Last fund: May invest from a new fund soon — raised $11M in 2019

Portfolio highlights

  • Voltrac — Building electric autonomous vehicles for farming & frontline logistics
  • enspired — Revolutionize battery storage with AI-powered BESS optimization. Our energy trading platform ensures smart, real-time market access. Contact us today!
  • Aitiologic — A precision medicine startup providing multi-modal liquid biopsy solutions for early disease detection and targeted therapy.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Lansdowne Partners
VC Fund · London, England, United Kingdom · 3 investments in Austria Biotech startups

Fundamental Equity Investing, since 1998

Show more...

Investment focus

  • Industry: Biotechnology, Finance, Genetics
  • Stage:Series A, Series B
  • Geography: United Kingdom, Austria, United States

Investor stats

  • Total investments: 46
  • Round size: Series A $6.7M–$55M; Series B $9.1M–$100M
  • Lead/follow: 20% lead, 80% follow
  • Last fund: May invest from a new fund soon — last raise in 2017

Portfolio highlights

  • MoA Technology — We harness the principles of natural selection to accelerate discovery for better, safer herbicides so farmers can continue to feed the world.
  • GALLOS Technologies — GALLOS is a company that co-builds & invests in security technology companies. Guiding security technology innovators to long-term success
  • amnis — Check out your possibilities to transfer money abroad, collect international payments and exchange currencies all in one account. Make payments fast with amnis.
Show all investments...

FPS-Holding
VC Fund · 3 investments in Austria Biotech startups

Investment focus

  • Industry: Biotechnology, Health Diagnostics
  • Stage:Seed
  • Geography: Austria

Investor stats

  • Total investments: 3
  • Round size: Seed $420k–$1.5M
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • Sola Diagnostics — Product: Sola Diagnostics’ WID®-easy test is a non-invasive epigenetic solution for detecting endometrial cancer in women with abnormal uterine bleeding. By analyzing DNA methylation markers from a simple vaginal swab, it offers high accuracy, reducing false positives and unnecessary surgeries. Target Audience: Designed for gynecologists andhealthcare providers, WID®-easy streamlines diagnostics, cutting costs and false alarms. Women benefit from a painless, accessible test that ensures earlier and more precise detection. Technology: Powered by advanced DNA methylation research, WID®-easy identifies cancer-specific epigenetic markers. With PCR-based analysis and robust clinical validation, it delivers fast, reliable results that integrate seamlessly into medical workflows. Market Positioning: WID®-easy fills a critical gap as a first-line diagnostic for abnormal uterine bleeding. Its clinical validation, accuracy, and cost-efficiency set it apart from invasive procedures. Its ease of use and scalability position it for widespread adoption. Milestones: Sola Diagnostics launched in Austria and Switzerland in 2024 and expanded to Great Britain in 2025. UKCA Marking was registered in December 2024. So far, private equity investments totaling €2.4M have supported Sola's mission to revolutionize women’s health diagnostics.
Show all investments...

BackBone Ventures
VC Fund · Zurich, Zurich, Switzerland · 2 investments in Austria Biotech startups

BackBone Ventures' focus are early-stage investments, primarly in the area of innovative ICT, FoodTech and disruptive technologies in DACH & Israel. Committed to achieve a positive impact for the next generation by empowering access to proficient ventures investments.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Information Technology
  • Stage:Pre-Seed, Seed, Series A
  • Geography: Switzerland, Germany, Israel

Investor stats

  • Total investments: 74
  • Round size: Seed $966k–$4M; Pre-Seed $578k–$2.8M; Series A $5M–$105M
  • Lead/follow: 26% lead, 74% follow

Portfolio highlights

  • eternal.ag — We help greenhouses overcome labor shortages through autonomous harvesting robots so they can keep operations running, every day, at scale.
  • Immitra Bio — Developing scalable in-vivo genomic medicine for blood disorders
  • NextBusiness — NextBusiness makes tools for founders in Switzerland. We build the AI-first business software infinity.swiss.
Show all investments...

Verge HealthTech Fund
VC Fund · Singapore, Central Region, Singapore · 2 investments in Austria Biotech startups

We make early investments in global healthcare technology companies that address prevention, disease management and health system efficiency that are relevant to emerging Asia​We believe that innovation can happen anywhere, from the streets of Dhaka to the labs of Oxford, however without the right support network, these solutions might notscale, or find the best world-changing application. This is where we can help.

Show more...

Investment focus

  • Industry: Health Care, Medical, Medical Device
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Estonia, Singapore, United States

Investor stats

  • Total investments: 30
  • Round size: Seed $500k–$4.7M; Pre-Seed $520k–$1M
  • Lead/follow: 57% lead, 43% follow
  • Last fund: Likely still investing — raised $250k in 2023

Portfolio highlights

  • THINKMD — THINKMD develops next-generation clinical assessment and data analytics platforms that transform point-of-care medicine by putting medically validated clinical assessment capability into the hands of non-healthcare professionals. This technology allows for the decentralization of healthcare delivery into communities and homes by pairing clinicalknowledge and Bayesian/pattern recognition algorithms with simple to use mobile technology. Its goal is to reinvent the healthcare delivery paradigm, reduce costs, and improve outcomes by improving healthcare access and care-seeking behavior while building a public health knowledge database.
  • Understanding Zoe — One calm home that remembers for you and grows with your family. Built in Australia for families raising neurodivergent children. Try free for 7 days.
  • Neuraworx Medical Technology — Neuraworx Medical Technology is a neurotechnology company developing first-in-class bioelectronic solutions for brain health.
Show all investments...

Simon Capital
VC Fund · Düsseldorf, Nordrhein-Westfalen, Germany · 2 investments in Austria Biotech startups

Simon Capital is an early-stage VC fund with €105M capital ready to invest in innovations that will improve our everyday lives, following the mission of investing “for the next generation”.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Food and Beverage
  • Stage:Series A, Seed, Series B
  • Geography: Germany, Austria, The Netherlands

Investor stats

  • Total investments: 22
  • Round size: Seed $1.8M–$9.3M; Series A $1.7M–$14M; Series B $32M–$57M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: Likely still investing — raised $110M in 2022

Portfolio highlights

  • VisioLab — Instantly scan products for self-checkout, using the iPad camera - no barcodes needed. Designed for speed, simplicity and human centricity.
  • Pacifico Biolabs — Pacifico Biolabs offers fermentation biotechnology for development, production and distribution of sustainable and food alternatives.
  • dsb Deutsche Sanierungsberatung — dsb Deutsche Sanierungsberatung provides easy and sustainable solutions for climate-friendly homes energy-efficient renovations for homeowners.
Show all investments...

Nina Capital
VC Fund · Barcelona, Catalonia, Spain · 2 investments in Austria Biotech startups, 11 in the past 12 months

We deploy early stage capital to fuel the growth of need-driven health technology companies.

Show more...

Investment focus

  • Industry: Health Care, Artificial Intelligence, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 96
  • Round size: Seed $2M–$6.3M; Pre-Seed $529k–$2.4M; Series A $5M–$21M
  • Lead/follow: 43% lead, 57% follow
  • Last fund: Likely actively investing — fresh fund, raised $52M in 2025

Portfolio highlights

  • Biobase — Biobase is the agentic system for clinical data, closing the gap between clinical data and better healthcare.
  • Ladder Health — Ladder Health offers virtual pediatric therapy and support for early childhood developmental delays, including speech and physical therapy.
  • Woodway Assurance — Woodway Assurance provides EviData, an AI-driven software for automated privacy assurance on de-identified and synthetic datasets.
Show all investments...

APEX Ventures
VC Fund · Vienna, Wien, Austria · 2 investments in Austria Biotech startups

APEX Ventures is a deep-tech and medical focused venture capital firm, run by founders with complimentary backgrounds driven by the same mission.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Health Care
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Germany, United Kingdom, Austria

Investor stats

  • Total investments: 62
  • Round size: Seed $1.4M–$8M; Pre-Seed $552k–$9.1M; Series A $5.7M–$28M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: May invest from a new fund soon — last raise in 2020

Portfolio highlights

  • Quibim — Quibim builds AI tools that turn MRI, CT and PET data into actionable predictions for hospitals and biopharma. Trusted in 230+ centers worldwide.
  • iPremom — iPremom is a healthcare technology company that develops molecular diagnostic solutions for the early detection and prediction of pregnancy complications, particularly preeclampsia.
  • Jago Coffee — Jago Coffee serves freshly brewed coffee beverages wherever you are through a fleet of fully electric mobile cafes.
Show all investments...

KHAN Technology Transfer Fund
VC Fund · Dortmund, Nordrhein-Westfalen, Germany · 2 investments in Austria Biotech startups

KHAN Technology Transfer Fund operates as an investment firm.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Biopharma
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Germany, Austria, Belgium

Investor stats

  • Total investments: 15
  • Round size: Seed $259k–$10M; Series A $5.6M–$10M
  • Lead/follow: 53% lead, 47% follow

Portfolio highlights

  • iDEL Therapeutics — iDEL Therapeutics is advancing a new class of cancer medicines by delivering therapeutic payloads directly into the cytosol of tumor cells through a unique, pan-cancer uptake mechanism.
  • KyDo Therapeutics — KyDo Therapeutics is a biotechnology company that develops novel covalent-allosteric small molecule inhibitors.
  • Revier Therapeutics — Revier Therapeutics is a biotechnology company focused on developing innovative solutions to improve human health and treat diseases.
Show all investments...

Hadean Ventures
VC Fund · Oslo, Oslo, Norway · 2 investments in Austria Biotech startups

Hadean Ventures is a life science fund manager that invests in life science companies across europe with a particular focus on the nordic region. The funds are backed by leading private and institutional investors. Hadean Ventures has offices in oslo and stockholm and collaborates with world-class academic institutions and start-up hubs across theregion

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Venture - Series Unknown
  • Geography: Sweden, Norway, Austria

Investor stats

  • Total investments: 34
  • Round size: Series A $4.2M–$79M; Series B $4.5M–$75M; Venture - Series Unknown $2M–$29M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely still investing — raised $168M in 2021

Portfolio highlights

  • Step Pharma — Step Pharma is a spin-off of Imagine Institute stemming from Pr. Alain Fischer’s research on genetic immunodeficiencies. Step Pharma is a joint venture between Imagine, a research and innovative healthcare institute, Sygnature Discovery, a leading provider of integrated drug discovery resource and expertise, and Kurma Partners, a major player inthe funding of healthcare and biotechnology in Europe.
  • ARTHEx Biotech — ARTHEx Biotech S.L. is a spin-off company of the University of Valencia that is developing advanced RNA treatments against genetic diseases.
  • TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Show all investments...

Longevitytech.fund
VC Fund · Prague, Hlavni mesto Praha, Czech Republic · 2 investments in Austria Biotech startups

Investing globally in technologies extending healthy lifespans

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Life Science
  • Stage:Seed, Convertible Note, Pre-Seed
  • Geography: United States, United Kingdom, The Netherlands

Investor stats

  • Total investments: 56
  • Round size: Seed $634k–$10M; Pre-Seed $100k–$3.6M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Whytics — DAGI: higher-level causal models from spatiotemporal coarse‑graining Whytics builds tools to reveal and validate macro‑causal structure—the stable, higher-level variables that appear when many parts of a system interact across space and time.
  • Klothea Bio — Klothea Bio is a protein well known for its powerful anti-aging capabilities, such as tumor suppression, neuroprotection, and antioxidative actions. As people age, their klotho levels drop to harmful levels. The metabolic disease syndrome will be the focus of the first investigations, while later studies will try to extend therapeutic applicationsto cancer, Alzheimer's disease, obesity, and other age-related diseases.
  • Yuva Biosciences — Using cutting edge mitochondrial science to develop cosmeceuticals and pharmaceuticals.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Übermorgen Ventures
VC Fund · Zürich, Zurich, Switzerland · 2 investments in Austria Biotech startups

We are an early stage VC for climate tech startups.

Show more...

Investment focus

  • Industry: Energy, Software, SaaS
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Germany, Switzerland, Finland

Investor stats

  • Total investments: 55
  • Round size: Seed $2.1M–$5.9M; Pre-Seed $300k–$4.1M; Series A $2.5M–$12M
  • Lead/follow: 22% lead, 78% follow

Portfolio highlights

  • Ecair — Ecair provides software for indoor air quality and energy management. The platform aggregates data from connected sensors to track pollutants, CO2, humidity, temperature, and particulate matter in real time. Dashboards, alerts, and APIs support building operations, facility managers, and ESG teams. Algorithms estimate exposure, flag ventilationissues, and suggest HVAC adjustments to balance comfort, health, and energy use. Reporting tools support certifications and compliance, and data exports integrate with BMS, CMMS, and data warehouses. Services include device provisioning, calibration management, and analytics consulting for multi-site portfolios.
  • Verna — Verna is a business using geospatial data science to address the climate and nature crises.We help landowners, investors, and policymakers to use land in ways that draw down carbon, enhance biodiversity and generate sustainable returns – e.g. through woodland creation, habitat creation and enhancement, and regenerative agriculture.Verna wasestablished in Borehamwood, Hertford.
  • Hyperion Robotics — We are accelerating the transition to sustainable and automated construction with Concrete 3D Printing.
Show all investments...

TSVC
VC Fund · Los Altos, California, United States · 2 investments in Austria Biotech startups

Founded in 2010, TSVC (formerly TEEC Angel Fund) is proud to be a leading early-stage venture capital fund in Silicon Valley.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Seed, Series A
  • Geography: United States, China, Canada

Investor stats

  • Total investments: 341
  • Round size: Seed $500k–$6.3M; Series A $2.7M–$44M
  • Lead/follow: 7% lead, 93% follow
  • Last fund: Likely actively investing — fresh fund, raised $20M in 2026

Portfolio highlights

  • Nvigen — NVIGEN is revolutionizing personalized medicine with highly accurate and NGS data efficient assays that provide integrative DNA, RNA, protein, cell, exosome information. Our mission is to improve health through our open platform of molecularly engineered nanoparticles and data-driven insights that help understand biological processes and reduce risks for aging, cancer, cardiovascular, neurodegenerative, and diabetic conditions.The NVIGEN X - Cancer Precision Profiling Test, now available for research use, supports early detection, monitoring, and treatment of cancer through accessible liquid biopsy tests. In line with our OpenVigen philosophy, we offer MagVigen and MyQuVigen nanoparticles to the biotech community, enabling high-sensitivity and high specificity immunoassays, genomic testing, molecular and cellular capture, and multiomics analysis. These products empower advancements in biomarker profiling, point-of-care testing, T-cell therapy, and precision diagnostics.
  • Dexmate — Dexmate is a robotics startup focused on developing general-purpose mobile robots. The company specializes in robots with manipulation capabilities. Their technology aims to enhance automation across various industries.
  • EGI Battery — EGI Battery is an American advanced battery cell manufacturer headquartered with design and operations in Ann Arbor, Michigan, U.S.
Show all investments...

The Austrian Research Promotion Agency (FFG)
VC Fund · Vienna, Wien, Austria · 2 investments in Austria Biotech startups

The Austrian Research Promotion Agency (FFG) is the national funding agency for industrial research and development in Austria. As a "one-stop shop" offering a diversified and targeted programme portfolio, the FFG gives Austrian businesses and research facilities quick and uncomplicated access to research funding.The FFG was foundedon 1 September 2004 (pursuant to the FFG Act on establishing a research promotion agency, Federal Law Gazette I No. 73/2004). The FFG is wholly owned by the Republic of Austria, represented by the Federal Ministry for Transport, Innovation and Technology (bmvit) and the Federal Ministry of Science, Research and Economy (BMWFW). As a provider of funding services, however, the FFG also works for other national and international institutions.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Medical
  • Stage:Grant, Seed, Pre-Seed
  • Geography: Austria, United States, Belgium

Investor stats

  • Total investments: 70
  • Round size: Seed $300k–$2.2M; Grant $67k–$3.5M; Pre-Seed $480k–$1.9M
  • Lead/follow: 27% lead, 73% follow

Portfolio highlights

  • OPTIMUSE — Optimuse provides an AI-based solution that supports the pre-design phase of building renovation. The platform converts building data into a digital twin to create accurate models for planning. It integrates data such as room types, thermal properties, and HVAC systems. The system runs energy simulations to calculate heating, cooling, lighting, andequipment needs. It helps design technical systems by defining the quantity, sizing, and configuration of components. The platform develops renovation plans by modeling financial, energy, and emissions outcomes. It also offers tools for cost calculation, performance monitoring, and collaboration across project teams.
  • sequestra — Sequestra is developing a technology platform that allows for permanent binding of CO₂ in industrial residues such as steel slag, incineration ash, and demolition waste while making the carbonated materials usable for construction applications.
  • Another Earth — Another Earth is building an AI-powered simulation and synthetic data platform for Earth Observation. As our planet changes, AI models need scalable, high-quality training data to keep pace. Another Earth provides synthetic data, scenario simulations and predictions required to accelerate AI development, and enable faster, smarterdecision-making—enabling smarter decisions for a more resilient world.
Show all investments...

Aescap Venture
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 2 investments in Austria Biotech startups

Aescap Venture is an Amsterdam-based investment company that pursues investments in biotech companies in Europe and the U.S.

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Health Diagnostics
  • Stage:Series B, Series A, Series C
  • Geography: Switzerland, United Kingdom, The Netherlands

Investor stats

  • Total investments: 20
  • Round size: Series A $1.5M–$20M; Series B $5.2M–$33M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: May invest from a new fund soon — last raise in 2016

Portfolio highlights

  • Orphazyme — Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disordes called lysosomal storage diseases, and is based on discoveries emerging from the academic laboratory of its scientific founders: Professor Marja Jäättela and Thomas Kirkegaard Jensen from the Danish Cancer Society (Kræftens Bekæmpelse).Orphazyme is based in Copenhagen and has established collaborations with top-tier academic institutions in Europe and USA.
  • Affectis Pharmaceuticals — Affectis is a pharmaceuticals company developing novel drugs for the treatment of neurodegenerative and neuroinflammatory diseases.
  • F-Star Therapeutics — F-star is a clinical stage biotech developing next generation immunotherapies to transform the lives of patients with cancer. We are developing transformational cancer immunotherapies for patients who have few remaining options.
Show all investments...

Axilium Holding
VC Fund · 2 investments in Austria Biotech startups

Axilium Holding

Show more...

Investment focus

  • Industry: Software, Human Resources, FinTech
  • Stage:Seed, Venture - Series Unknown
  • Geography: Sweden, Austria

Investor stats

  • Total investments: 4
  • Round size: Seed $450k–$7.3M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Planacy — Planacy is a modern and flexible planning platform that is built to handle a complex reality. With Planacy you will get a tailor-made platform that is adjusted just for your business needs, a platform that you can easily develop when your prerequisites changes. By smart and seamless integrations to your BI platforms from Power BI®, Qlik® orTableau®, Planacy decreases the time consuming manual and repetitive work and supports your business with a fast, safe, more collaborative and flexible process. Together with an intuitive and smooth user interface your planning process will be simpler and more fun with more time to spend on the more value creating work as a result.
  • Sarcura — Sarcura GmbH is an Austrian deep-tech startup developing an instrument platform for the industrial manufacturing of advanced cell therapies. Our platform combines silicon chip technology and microfluidic processing to enable real-time process control and manipulation on a cellular level, enabling a fully automated and modular manufacturing system..
  • WorkNode — Worknode is shaping the future of work. With modern technology and a deep understanding of labor market dynamics, we make flexible work safe, simple, and sustainable for both individuals and companies.For individuals, Worknode enables earning and getting paid like an employee without starting a company. For businesses, we provide a digitalemployer-of-record service that streamlines the management of external talent with full compliance, transparency, and efficiency.By building the digital infrastructure for a more flexible workforce, Worknode creates new opportunities for people to shape their careers and for companies to scale with the right skills at the right time. More than a platform, Worknode is a partner in driving a modern, dynamic, and inclusive way of working.
Show all investments...

MCI Capital SA
VC Fund · Warsaw, Mazowieckie, Poland · 2 investments in Austria Biotech startups

MCI Capital is a leading Digital Private Equity investor in CEE, based in Warsaw, Poland. MCI Capital seeks to invest in digital disruption, transformation and infrastructure within EU, with focus on CEE. Preferred sectors are SaaS, E-commerce, Marketplace, Fintech, Insurtech, Foodtech, Traveltech and Digital Infrastructure. MCI typically investsEUR 25-100 M in a single project, either in Buyout or Expansion stage. Historically, MCI Capital has also been involved in funds dedicated to Private Debt, Growth and Venture Capital areas – these funds do not conduct any new investments, instead they focus on building the value of assets and de-investing.MCI Capital is managed by the executive management team. The company is listed on the Warsaw Stock Exchange since February 2001 and is also a member of the Polish Private Equity Association.

Show more...

Investment focus

  • Industry: E-Commerce, Software, Financial Services
  • Stage:Series A, Venture - Series Unknown, Series C
  • Geography: Poland, United Kingdom, Germany

Investor stats

  • Total investments: 57
  • Round size: Series A $603k–$9.6M; Series C $5.5M–$45M; Venture - Series Unknown $798k–$12M
  • Lead/follow: 63% lead, 37% follow
  • Last fund: May invest from a new fund soon — raised $15M in 2011

Portfolio highlights

  • Windeln.de — windeln.de, together with its subsidiaries, operates as an online retailer of products for babies, toddlers, children, and young mothers in Germany, Austria, Switzerland, the Czech Republic, Spain, and China. It operates through German Shop, International Shops, and Shopping Clubs segments. The company offers a range of products, including diapers,baby food, drugstore products, clothes, toys, strollers, child car seats, baby monitors, and children’s furniture.
  • ANSWEAR.com — 200 fashion brands with free delivery in 24h!
  • Telematics Technologies — Telematics Technologies sp. z o.o., a Polish technology company, until December 2017 operating as NaviExpert sp. z o.o. The company is a leading provider of insurance telematics and premium navigation solutions for smartphones on the Polish market. The company's portfolio also includes, among others, a system for managing fleets of vehiclesup to 3.5 tonnes called NaviExpert Telematics. In terms of telematics insurance, since 2015 Telematics Technologies has been working with PZU Group, which is one of the largest financial groups in Central and Eastern Europe. As a result of cooperation between the entities, the first offers of Usage-Based Insurance appeared on the Polish market (Safe driving with LINK4, LINK4 Cash Returns) as well as offers of accident detection and reconstruction (PZU GO). Individual customers know Telematics Technologies primarily as a navigation application provider NaviExpert. The application is available on the market under its own brand, as well as in a white label model in offers of all mobile network operators in Poland as Navigation Orange, Navigation Play, Navigation Plus, Navigation T-Mobile. Every month, the system is used by nearly 600 thousand paying users. The company creates solutions that aim to increase road safety by improving drivers' driving styles. Since 2012, the company's CEO has been Adam Bąkowski. The majority shareholder of Telematics Technologies company is Noble Fund Private Debt Fundusz Inwestycyjny Zamknięty Aktywów Niepublicznych with its registered office in Warsaw.
Show all investments...

Gamma Capital Partners
VC Fund · Vienna, Wien, Austria · 2 investments in Austria Biotech startups

gcp gamma capital partners is an independent Venture Capital investment firm, focused on financing dynamic technology companies in Austria, Germany, Switzerland and CEE countries.They seek to achieve superior returns by finding assets with substantial potential in their regional and sectoral focus areas, before they appear on the radar screenof mainstream players in terms of stage and/or initial investment size.

Show more...

Investment focus

  • Industry: Software, Manufacturing, Information Technology
  • Stage:Series A, Seed
  • Geography: Austria, United States, Germany

Investor stats

  • Total investments: 29
  • Round size: Seed $409k–$3M; Series A $1.3M–$8M
  • Lead/follow: 21% lead, 79% follow
  • Last fund: May invest from a new fund soon — last raise in 2010

Portfolio highlights

  • Fatfoogoo — Building microtransaction payment systems for Developers, Publishers, and Operators
  • Infoniqa Group — The Infoniqa Group combines twenty years of IT experience and a new, trend-setting business, which enables networking advantages and which corresponds to the requirements of their customers - typically international medium and large enterprises and institutions.
  • GAT Microencapsulation — OMPONG188 menjadi tempat untuk mengakses halaman resmi game online melalui link alternatif bebas IP yang banyak disukai oleh para pengguna hiburan digital.
Show all investments...

SkyGene
VC Fund · Austria, Pangasinan, Philippines · 2 investments in Austria Biotech startups

SkyGene is a venture capital firm. The firm intends to invest in biotech firms.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Venture - Series Unknown
  • Geography: Austria

Investor stats

  • Total investments: 2
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • VALANX Biotech — VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.
Show all investments...

HTGF (High-Tech Gruenderfonds)
VC Fund · Bonn, Nordrhein-Westfalen, Germany · 2 investments in Austria Biotech startups

High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in varioussectors.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Information Technology
  • Stage:Seed, Series A
  • Geography: Germany, Switzerland, United States

Investor stats

  • Total investments: 739
  • Round size: Seed $850k–$7M; Series A $3.1M–$31M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely still investing — raised $515M in 2022

Portfolio highlights

  • Zimory — Founded in 2007, Zimory provides carrier-grade cloud infrastructure management software that allows service providers, enterprises and cloud brokers to fully leverage the power and elasticity of cloud computing. Zimory’s intelligent Cloud Suite simplifies, automates and expedites the creation, launch and management of all types of cloudenvironments – whether public, private, virtual private or hybrid. Zimory software is also a key enabler of cloud marketplaces for enterprise services, applications and infrastructure. Headquartered in Berlin, Zimory has development centers in Erfurt, Germany and Minsk, Belarus, a subsidiary office in New York City and is expanding its expertise and presence globally.
  • Alteva — Alteva develops battery cells for the decarbonisation of the global transport sector, and focus on high-energy density battery cells with high safety profiles specifically designed for the aviation and heavy-duty transport sectors.
  • Smartblue — Smartblue develops and runs software and processes to monitor and optimize zero emission energy systems. As a hardware independent specialist Smartblue delivers a software service for the maintenance, life-cycle management, production forecasting and remote control of photovoltaic and energy storage systems all together in one centralized “SmartControl” Operations and Control Center web application. We help our customers drive down overall operational cost through automation, smart failure detection and big data analysis on imminent defects.
Show all investments...

Schnidar Harald
Angel · Vienna, Wien, Austria · 2 investments in Austria Biotech startups

Entrepreneur, Angel Investor, Scientist and Inventor

Show more...

Investment focus

  • Industry: Software, Biopharma, Cosmetics
  • Stage:Seed, Angel, Pre-Seed
  • Geography: Austria

Investor stats

  • Total investments: 7
  • Lead/follow: 86% lead, 14% follow

Portfolio highlights

  • SCARLETRED — SCARLETRED is an international Digital Health Scaleup revolutionising the global skin care market by the AI powered SCARLETRED®VISION platform system. The problem we solved is subjective skin assessment and lacking standardization in Dermatology. Our medical device certified platform is fully mobile, runs via mobile App on smartphones and connectsto our web platform, which enables to generate smart imaging data and novel AI decision support applications in Dermatology and Telemedicine. The multi award winning technology is supplied international via SaaS to Biopharma and Cosmetics Industry, Hospitals and Medical Experts. Protected via worldwide patents it facilitates standardized skin documentation and remote tracking of skin changes and therapeutic effects via mobile App. Images can be uploaded in a cloud based platform and objectively analysed for visual skin changes over time, such as for allergic reactions, pigmentation changes, acne, psoriasis, disease or wound healing. SCARLETRED provides services on a broad range of dermatologic conditions ranging from B2B to B2B2C applications.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
GreyBird Ventures
VC Fund · Concord, Massachusetts, United States · 2 investments in Austria Biotech startups

GreyBird Ventures medical technology firm and invests in companies developing products for precision medicine.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Seed
  • Geography: United States, Germany, China

Investor stats

  • Total investments: 11
  • Round size: Seed $3M–$5M; Series A $3M–$16M
  • Lead/follow: 91% lead, 9% follow

Portfolio highlights

  • NeuroKaire — Genetika+ is revolutionzing depression treatment. Using biological, medical and genetic data, GenetikaPlus develops personalized solution for every patient to help them recover better, faster.
  • Platomics — Platomics provides a regulatory compliant digital infrastructure and network for every laboratory to setup and run genetic tests.
  • Angstrom Bio — We Apply Machine Learning And Novel Nucleotide Chemistry to the Diagnosis and Treatment Of Disease. Unparalleled Diagnostic Scale. Better Drugs, Faster.
Show all investments...

Open Field Capital
VC Fund · New York, New York, United States · 2 investments in Austria Biotech startups

Open Field Capital

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Machine Learning
  • Stage:Venture - Series Unknown, Series A, Seed
  • Geography: United States, Austria, United Kingdom

Investor stats

  • Total investments: 32
  • Round size: Seed $3.1M–$30M; Series A $8.7M–$350M; Venture - Series Unknown $150k–$6.2M
  • Lead/follow: 0% lead, 100% follow
  • Last fund: Likely actively investing — fresh fund, raised $2.3M in 2024

Portfolio highlights

  • Groq — Groq is a technology company that designs and provides specialized artificial intelligence compute solutions focused on accelerating AI inference workloads using its custom-built Language Processing Unit (LPU) hardware and associated software stack. The company’s core products include purpose-designed silicon and cloud-accessible platforms thatsupport real-time execution of large language models and other AI tasks with low latency and high throughput, enabling developers and enterprises to integrate AI services into production environments efficiently. Groq also delivers cloud-based services that allow customers to access inference capabilities via APIs compatible with popular development tools, supporting seamless integration into existing AI workflows. Its engineering efforts emphasise deterministic performance and streamlined deployment, targeting use cases where speed and cost predictability are critical. Groq engages with partners and customers across sectors that require rapid AI inferencing, and the company’s technology has attracted significant strategic interest and investment within the broader AI infrastructure ecosystem.
  • Numenta — Powerful, Neuroscience-Based AI
  • Paragraf — We Work to Develop Innovative and Useful End Products from Novel Materials. Our Analogue Sensors Are Designed to Provide Accurate Field Gradient Mapping & Alignment.
Show all investments...

bmp Ventures
VC Fund · Berlin, Berlin, Germany · 2 investments in Austria Biotech startups, 7 in the past 12 months

bmp Ventures is an innovative Venture Capital Company from Berlin. Since 1997 we’ve been investing Smart Money in Early Stage and Growth Startups. We finance ingenious business models with outstanding teams, who build fast-growing and sustainably profitable enterprises.

Show more...

Investment focus

  • Industry: Software, Information Technology, Manufacturing
  • Stage:Seed, Series A
  • Geography: Germany, United States, Austria

Investor stats

  • Total investments: 122
  • Round size: Seed $162k–$3.6M; Series A $912k–$5.9M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: Likely actively investing — fresh fund, raised $70M in 2024

Portfolio highlights

  • Lab Thunder — LabThunder provides a cloud-based laboratory management software platform designed to digitize operational workflows. The system centers on centralizing equipment management, automated maintenance scheduling, digital logbooks, and AI-supported knowledge management to ensure audit-ready compliance.
  • Sedivention — Fight obesity within 20 minutes - fast, effective, long-term. A new weight-loss therapy for the treatment of obesity. Just a view minutes will change your life.
  • Solar Materials — Solar Materials primarily engages in the development of technologies for the sustainable and economical recycling of solar modules.
Show all investments...

R42 Group
VC Fund · Stanford, California, United States · 2 investments in Austria Biotech startups

R42 Group is a venture fund and an institute which invents, invests and informs covering AI, deep science, 5G mobile, biotech and fintech.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, United States, Austria

Investor stats

  • Total investments: 35
  • Round size: Seed $754k–$8M; Pre-Seed $472k–$2M; Series A $4.2M–$40M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: Likely actively investing — fresh fund, raised $5.3M in 2025

Portfolio highlights

  • xWatts — xWatts is an intelligent energy management software that reduces energy costs and emissions in commercial buildings.
  • Stamp Free — stampfree.ai Digital Shipping Solutions enables customers to send parcels and returns with just a phone conveniently and securely.
  • Cordance Medical — Improving outcomes for patients with brain diseases
Show all investments...

ICL Planet Startup Hub
VC Fund · Tel Aviv, Tel Aviv, Israel · 2 investments in Austria Biotech startups

ICL Startup Accelerator focuses on foodtech and crop nutrition startups, innovative products, and accelerates their market penetration

Show more...

Investment focus

  • Industry: Biotechnology, Agriculture, AgTech
  • Stage:Seed
  • Geography: Israel, Austria

Investor stats

  • Total investments: 4
  • Round size: Seed $4.3M–$10M
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • Agrematch — Agrematch is a data driven small molecules product discovery, development and marketing company, catering to the agricultural industry. Our novel Ag products discovery engine utilizes big-data science, biology, chemistry, and ag know-how to bring new crop protection products to market.
  • Lavie bio — LaVie Bio develops bacterial compositions that are sprayed on plants, used to coat seeds, or are integrated in the soil around the plant in order to improve the crop or the plant's features.
  • Arkeon Biotechnologies — Arkeon converts CO2 into resources to power tomorrow's industries.
Show all investments...

Ligand Pharmaceuticals
VC Fund · San Diego, California, United States · 2 investments in Austria Biotech startups

A genetic medicines company developing first-in-class, non-viral, targeted nucleic acid therapeutics utilizing a proprietary gene monoclonal antibody (GMAB) platform technology.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Post-IPO Debt, Corporate Round, Post-IPO Equity
  • Geography: United States, Austria, Denmark

Investor stats

  • Total investments: 19
  • Round size: Post-IPO Debt $15M–$85M; Corporate Round $3M–$10M; Post-IPO Equity $15M–$90M
  • Lead/follow: 58% lead, 42% follow

Portfolio highlights

  • Agenus — Activating the Power of the Immune System to Defeat Cancer
  • Zerion Pharma — Zerion Pharma is a pharmaceutical company that aims to transform the pharmaceutical landscape with a new formulation technology. The company is focused on improving existing drugs by building an internal pipeline to solve the most challenging drug solubility problems that pharmaceutical companies face. Zerion Pharma was founded in 2019 and isbased in Birkerød, Denmark.
  • Castle Creek Biosciences — Dedicated to making life better for people suffering from rare diseases with few or no treatment options
Show all investments...

red-stars.com
VC Fund · 2 investments in Austria Biotech startups

We back B2B software and life-sciences companies with limitless scalability.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Telecommunications
  • Stage:Seed, Venture - Series Unknown
  • Geography: Austria, Germany

Investor stats

  • Total investments: 11
  • Round size: Seed $1.1M–$4.4M
  • Lead/follow: 82% lead, 18% follow

Portfolio highlights

  • Txture — IBM Consulting uses IBM Txture to help organizations assess application portfolios, plan cloud modernization and build data-driven transformation strategies.
  • HeartBeat.bio — HeartBeat.bio is a privately funded drug discovery company focusing on the development of a high-throughput 3D screening platform for heart failure and cardiomyopathies.
  • MAVOCO — We create a carrier-grade software for IoT champions, trusted by tier-1 Mobile network operators.
Show all investments...

VP Venture Partners
VC Fund · Zürich, Zurich, Switzerland · 2 investments in Austria Biotech startups

VP Venture Partners is a venture capital firm invests in healthcare companies.

Show more...

Investment focus

  • Industry: Medical, Health Diagnostics, Internet
  • Stage:Seed
  • Geography: Austria, Switzerland

Investor stats

  • Total investments: 7
  • Round size: Seed $3M–$6.9M
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • Diamens — Diamens is a company focused on femtech that develops a non-invasive menstrual blood-based molecular diagnostic to detect women-specific diseases like endometriosis.
  • Moonlight AI — Moonlight AI was created to democratize the access to genomic information that is essential for therapy decision making in the era of personalized medicine.
  • CollimateHealth — CollimateHealth is creating a clinically scalable microbeam radiation technology that will revolutionize the treatment of cancer.
Show all investments...

eQventure
VC Fund · Graz, Steiermark, Austria · 2 investments in Austria Biotech startups

Entrepreneurs for Entrepreneurs

Show more...

Investment focus

  • Industry: Software, Information Technology, Automotive
  • Stage:Seed, Series A, Series B
  • Geography: Austria, Germany, Switzerland

Investor stats

  • Total investments: 67
  • Round size: Seed $540k–$1.2M; Series A $781k–$5.6M; Series B $4.2M–$13M
  • Lead/follow: 78% lead, 22% follow

Portfolio highlights

  • Diamens — Diamens is a company focused on femtech that develops a non-invasive menstrual blood-based molecular diagnostic to detect women-specific diseases like endometriosis.
  • Respory — Respory provides real-time people-tracking using proprietary radar sensors, all without capturing personal data. Our scalable sensor network, powered by AI-driven algorithms, delivers precise customer journey insights, critical for in-store performance in retail.
  • 2nd Cycle — 2nd Cycle creating a cost-effective, fully automated, and scalable solution for modules for a second life cycle.
Show all investments...

Novartis Venture Fund
VC Fund · Basel, Basel-Stadt, Switzerland · 1 investments in Austria Biotech startups

Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series A, Series C
  • Geography: United States, Switzerland, United Kingdom

Investor stats

  • Total investments: 213
  • Round size: Series A $5.1M–$81M; Series B $11M–$120M; Series C $9M–$75M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — raised $200M in 2009

Portfolio highlights

  • Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
  • Bionano Genomics — Discover how Bionano is striving to elevate health and wellness for all through optical genome mapping (OGM) solutions that transform the way the world sees the genome.
  • LOQUS23 THERAPEUTICS — LoQus23 is a DDF-formed company focussing on targeting DNA damage repair pathways to treat Huntington’s disease and other triplet repeat diseases.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Synthesis Capital
VC Fund · London, England, United Kingdom · 1 investments in Austria Biotech startups

Synthesis Capital is an investment manager transforming our food system through food technology.

Show more...

Investment focus

  • Industry: Biotechnology, Food and Beverage, Organic Food
  • Stage:Seed, Series A, Series C
  • Geography: United States, Israel, Austria

Investor stats

  • Total investments: 10
  • Round size: Seed $7.1M–$9M; Series A $20M–$23M
  • Lead/follow: 60% lead, 40% follow

Portfolio highlights

  • Triplebar — Triplebar provides sustainability, biotechnology, and synthetic biology research.
  • Savor — Savor makes delightfully rich foods without animals, farmland, fertilizers, hormones, or antibiotics.
  • Culture Biosciences — Culture Biosciences develops automated bio-reactor that helps biotech companies optimize their manufacturing processes and brings products to market faster. The company also builds automated tools for fermentation. It has a digital bio-manufacturing platform to enable scientists to run, monitor, and analyze bio-reactors faster than traditionalapproaches by robotic sample handling and cloud data monitoring and analysis.Culture Biosciences was founded in 2016 and is headquartered in San Francisco, California.
Show all investments...

HBM Partners
VC Fund · Zug, Zug, Switzerland · 1 investments in Austria Biotech startups

HBM Partners focuses on venture, growth and buy-out financings of private companies as well as investments in public companies.The HBM funds invest in entrepreneurial biopharma and other healthcare-related companies in Europe, North America, India and other Emerging Markets. Their team supports the growth of the portfolio companies through allstages of development, focusing on adding value by leveraging its experience and HBM's world-wide network in the industry. Investments usually range between $5 million to $50 million.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series B, Series C
  • Geography: United States, Germany, Switzerland

Investor stats

  • Total investments: 41
  • Round size: Series B $7.7M–$125M; Series C $2.5M–$113M
  • Lead/follow: 17% lead, 83% follow
  • Last fund: May invest from a new fund soon — raised $105M in 2012

Portfolio highlights

  • Dren Bio — Dren Bio is a biotechnology company with a portfolio of attractive projects focused on powerful protein engineering technologies for the depletion of cells, protein aggregates, and other disease-causing agents. It is a holding company business model aimed at creating value with multiple projects as stand-alone assets.
  • AtaiBeckley — We are a clinical-stage biopharmaceutical company developing new mental health treatments to transform patient outcomes.
  • Mineralys Therapeutics — Evolving science is revealing the importance of aldosterone in cardio-renal-metabolic diseases.We are focused on improving outcomes for people managing hypertension, CKD and related diseases that are driven by dysregulated aldosterone. About Aldosterone
Show all investments...

Amino Collective
VC Fund · Berlin, Berlin, Germany · 1 investments in Austria Biotech startups, 6 in the past 12 months

Amino Collective is an institutional venture capital firm investing at seed stage in health and bio companies. They help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, lifescience, and synthetic biology.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Artificial Intelligence
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 46
  • Round size: Seed $2.4M–$14M; Pre-Seed $125k–$7.8M; Series A $12M–$37M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Calibre — Diagnostic testing, clinicians, and AI working together to help you deeply understand your health and how to improve it.
  • Modern Relay — Modern Relay provides context graph for enterprise AI.
  • Tandem Health — Focus on providing care, while Tandem helps you easily write medical notes directly after the patient consultation.
Show all investments...

OrbiMed
VC Fund · New York, New York, United States · 1 investments in Austria Biotech startups

Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, China, Israel

Investor stats

  • Total investments: 653
  • Round size: Series A $10M–$150M; Series B $24M–$150M; Series C $18M–$183M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • CardiAQ Valve Technologies — CardiAQ Valve Technologies (CVT), a privately held company, is developing innovative approaches to heart valve replacement and is initially focused on transcatheter mitral valve implantation (TMVI).
  • Sonendo — Sonendo developing innovative technologies to transform dentistry by Saving Teeth Through Sound Science®. The GentleWave® System shows significant improvements in clinical efficacy and practice efficiency when compared to standard root canal treatment.1,2, 3 Sonendo is the parent company of TDO® Software, the developer of the most widely usedendodontic practice management software in the world, designed to simplify practice workflow. TDO software seamlessly integrates practice management, imaging, social media, referral reporting, CBCT imaging, and offers built-in communication with the GentleWave System.
  • Acceleron Pharma — At Merck, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Show all investments...

PONTIS Venture Partners Management
VC Fund · Vienna, Wien, Austria · 1 investments in Austria Biotech startups

PONTIS Capital manages two funds with total commitments of more than EUR 60 million, and is actively investing out of its second fund, PONTIS Growth Capital II (“PGC II”). The focus of PGC II is to invest in small and medium-sized growth companies with Established technology or other competitive advantage Existing proof-of-market in marketswith growth potential,Scalable business models, andHeadquarters in the DACH region (Germany, Austria, Switzerland)

Show more...

Investment focus

  • Industry: Software, Manufacturing, Information Technology
  • Stage:Series A, Series B, Series C
  • Geography: Austria, Germany

Investor stats

  • Total investments: 5
  • Lead/follow: no public data

Portfolio highlights

  • evidanza — evidanza GmbH is a software provider of business intelligence solutions for reporting, planification, OLAP-analysis, risk management, costs calculations, IFRS- and USGAAP-reporting. The company is headquartered in Salching, Germany.
  • SensorDynamics — SensorDynamics was a European semiconductor and MEMS company specialized in developing and manufacturing high-volume micro- and wireless semiconductor sensor products for applications in automotive, industry and high-end consumer sectors. The company was acquired by Maxim Integrated in 2011 for $164 million. SensorDynamics developed and producedcustom-made designs and standard components for use in vehicle stabilization, occupant protection, navigation systems, keyless go systems and autonomous energy generators for wireless and battery free controllers for industrial, automotive and high-end consumer application.[5] With its headquarters in Graz, Austria, SensorDynamics had offices in Italy and Germany and a worldwide sales and distribution network. The company employed about 130 people in 2011.
  • EUCODIS Bioscience — EUCODIS Bioscience is an experienced enzyme engineering company, providing industrial customers with high-performing enzymes. Their customers are leaders in the chemical, the pharmaceutical, the food and feed and cosmetics industries.
Show all investments...

IPO Beteiligungs-Management
VC Fund · Vienna, Wien, Austria · 1 investments in Austria Biotech startups

IPO Beteiligungs-Management is a private equity company specialized in early stage venture investments.

Show more...

Investment focus

  • Industry: Sensor, Medical, Wireless
  • Stage:Series B
  • Geography: Austria

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • SensorDynamics — SensorDynamics was a European semiconductor and MEMS company specialized in developing and manufacturing high-volume micro- and wireless semiconductor sensor products for applications in automotive, industry and high-end consumer sectors. The company was acquired by Maxim Integrated in 2011 for $164 million. SensorDynamics developed and producedcustom-made designs and standard components for use in vehicle stabilization, occupant protection, navigation systems, keyless go systems and autonomous energy generators for wireless and battery free controllers for industrial, automotive and high-end consumer application.[5] With its headquarters in Graz, Austria, SensorDynamics had offices in Italy and Germany and a worldwide sales and distribution network. The company employed about 130 people in 2011.
  • EUCODIS Bioscience — EUCODIS Bioscience is an experienced enzyme engineering company, providing industrial customers with high-performing enzymes. Their customers are leaders in the chemical, the pharmaceutical, the food and feed and cosmetics industries.
Show all investments...

IBG Beteiligungsgesellschaft Sachsen-Anhalt
VC Fund · Magdeburg-rothensee, Sachsen-Anhalt, Germany · 1 investments in Austria Biotech startups

IBG Beteiligungsgesellschaft Sachsen-Anhalt is a venture capital firm makes investments in territories such as Germany and Denmark.

Show more...

Investment focus

  • Industry: Electronics, Software, Medical Device
  • Stage:Seed, Series A
  • Geography: Germany, Austria

Investor stats

  • Total investments: 12
  • Lead/follow: no public data

Portfolio highlights

  • Livil — Livil provides a toolkit for designing and delivering flexible employee benefits, including lifestyle, dental, and vision plans.
  • Wingfield — Wingfield develops a system intended to transform any tennis court in the world into a smart court. The system is a combination of hardware and artificial intelligence and keeps track of the score, analyzes strokes and gives personal feedback right after matches or practice sessions and the system only costs a fraction of a professional system andis easily set up, enabling players to get the same game analytics as the professionals do.
  • Baby Sweets — Baby Sweets provides Online shop for beautiful and unusual baby clothes and accessories.Sales of own brands made in EU as well as international brands.
Show all investments...

ReGen Ventures
VC Fund · Byron Bay, New South Wales, Australia · 1 investments in Austria Biotech startups

Investing in the ReGeneration

Show more...

Investment focus

  • Industry: Agriculture, Biotechnology, Farming
  • Stage:Seed, Series A, Series B
  • Geography: United States, Austria, United Kingdom

Investor stats

  • Total investments: 19
  • Lead/follow: no public data

Portfolio highlights

  • Anthrogen — Anthrogen is a Biotechnology Research firm using bacteria and enzymes for reducing carbon in the air by transforming it into chemicals.
  • Asterix Foods — Asterix Foods is a biotechnology company designed to build protein production using plant-cell culture techniques. The company's platform is developing and growing bioactive proteins for food that are scalable, functional, and complex, enabling users with plant cell-cultured and animal-free proteins.It was founded in 2022 and is located inTel Aviv, Israel.
  • Differential Bio — Differential Bio is integrating scale-down experiments with AI-based modeling to optimize how industry-relevant microbes grow ("biomass fermentation") and produce ("precision fermentation"). By optimizing bioprocesses and growth conditions, the company is not only increasing their clients' R&D efficiency but alsodramatically improving bioproduction outcomes such as yield, cost efficiency, and product quality.
Show all investments...

Climentum Capital
VC Fund · Copenhagen, Hovedstaden, Denmark · 1 investments in Austria Biotech startups

A Venture Capital firm investing into European early-stage tech companies attacking CO2 emissions

Show more...

Investment focus

  • Industry: CleanTech, Clean Energy, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: Sweden, Spain, Austria

Investor stats

  • Total investments: 16
  • Lead/follow: no public data

Portfolio highlights

  • Novatron — A new fusion reactor design for stable plasma confinement and fusion power generation.
  • Wayout International — WAYOUT offers complete water production systems for local coverage of perfect drinking water on a commercial platform with minimal eco footprint.
  • ZeroPoint Technologies — ZeroPoint Technologies AB was created in 2016 as a spinout from Chalmers University of Technology. The Intellectual Property Portfolio related to computer memory management was the acquired from the University and transferred into a new startup.The Technology, ideas and many of the people behind and with ZeroPoint comes from Professor PerStenströms research group, which is internationally recognized for excellence within high-performance Computing. Since its creation, ZeroPoint has attracted skilled people from industry, finance and the startup community and raised its’ first round of Venture Capital in 2016.
Show all investments...

Techno Venture Management
VC Fund · Boston, Massachusetts, United States · 1 investments in Austria Biotech startups

Techno Venture Management is a venture capital and private equity firm focused on healthcare industry.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Series B, Series A
  • Geography: United States, Germany, United Kingdom

Investor stats

  • Total investments: 99
  • Lead/follow: no public data

Portfolio highlights

  • Streaming21 — Streaming21 is a solution provider of seamless on-demand and IP broadcasting service platform for connected digital home.
  • Helomics — Helomics® is a comprehensive personalized healthcare company, bringing the next generation of diagnostics to the oncology field. Helomics is dedicated to improving patient outcomes by providing a personalized comprehensive tumor profile utilizing a proprietary set of laboratory platforms that leverage both tissue-based live and fixed cellular basedanalysis allowing physicians to characterize malignant tumors on a personalized basis. Helomics’ novel molecular and cellular markers and bioinformatics services support treatment decisions by providing vital information based on the specific biological processes of each individual’s cancer.
  • Precision Therapeutics — Precision Therapeutics is a pharmaceutical research and development business that develops personalized cancer treatments for patients.
Show all investments...

Biotech Investor funding in Austria at a glance

Stats across 185 deals from 205 investors.

205
investors
in Austria Biotech startups
185
deals
in Austria Biotech startups
$2.8M
median round
in Austria Biotech startups
48%
lead investors
lead at least one round
27%
Seed
most common funding stage
96/4
VC / Angel
share of investor count

Access all 205 investors in Austria Biotech startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotech Investors in Austria investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 205 investors investing in Austria Biotech startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists